Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 14.

Journal Article

Berendt, J., Oechsle, K., Thomas, M., van Oorschot, B., Schmitz, A., Radbruch, L., Simon, S., Gaertner, J., Thuss-Patience, P., Schuler, U., Hense, J., Gog, C., Viehrig, M., Mayer-Steinacker, R., Stachura, P., Stiel, S. and Ostgathe, C. (2016). Palliative Care at Comprehensive Cancer Center: A comparative look at integration in Germany. Oncol. Res. Treat., 39. S. 129 - 130. BASEL: KARGER. ISSN 2296-5262

Berendt, J., Oechsle, K., Thomas, M., van Oorschot, B., Schmitz, A., Radbruch, L., Simon, S. T., Gaertner, J., Thuss-Patience, P., Schuler, U. S., Hense, J., Gog, C., Viehrig, M., Mayer-Steinacker, R., Stachura, P., Stiel, S. and Ostgathe, C. (2016). State of integration of palliative care at Comprehensive Cancer Centers funded by German Cancer Aid. Dtsch. Med. Wochenschr., 141 (2). S. E16 - 8. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Griesinger, F., Buettner, R., Deppermann, K-M, Reinmuth, N., Schuette, W., Thomas, M., Wroblewski, M. and Schumann, C. (2018). Real world molecular testing in patients with EGFR mutation-positive locally advanced or advanced NSCLC in routine practice in Germany - Interim results of the clinical registry PANORAMA. Oncol. Res. Treat., 41. S. 249 - 250. BASEL: KARGER. ISSN 2296-5262

Griesinger, F., Buettner, R., Deppermann, K. -M., Reinmuth, N., Schuette, W., Thomas, M., Bergner, S. and Schumann, C. (2017). PANORAMA - Real world molecular testing, treatment patterns, and clinical outcomes in patients with EGFR mutation-positive locally advanced or advanced NSCLC. Oncol. Res. Treat., 40. S. 248 - 250. BASEL: KARGER. ISSN 2296-5262

Griesinger, F., Buettner, R., Deppermann, K. M., Reinmuth, N., Schuette, W., Thomas, M., Wroblewski, M. and Schumann, C. (2020). Real World Molecular Testing in Patients with EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC in routine practice in Germany - Interim Results of the clinical registry PANORAMA. Pneumologie, 74. S. S128 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790

Kim, D., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., De Pas, T., Riely, G. J., Solomon, B. J., Wolf, J., Thomas, M., Schuler, M., Liu, G., Santoro, A., Geraldes, M., Boral, A. L., Yovine, A. and Shaw, A. T. (2014). Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC): An Update of ASCEND-1. Int. J. Radiat. Oncol. Biol. Phys., 90. S. S33 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X

Marecal, V., Peuch, V. -H., Andersson, C., Andersson, S., Arteta, J., Beekmann, M., Benedictow, A., Bergstrom, R., Bessagnet, B., Cansado, A., Cheroux, F., Colette, A., Coman, A., Curier, R. L., van der Gon, H. A. C. Denier, Drouin, A., Elbern, H., Emili, E., Engelen, R. J., Eskes, H. J., Foret, G., Friese, E., Gauss, M., Giannaros, C., Guth, J., Joly, M., Jaumouille, E., Josse, B., Kadygrov, N., Kaiser, J. W., Krajsek, K., Kuenen, J., Kumar, U., Liora, N., Lopez, E., Malherbe, L., Martinez, I., Melas, D., Meleux, F., Menut, L., Moinat, P., Morales, T., Parmentier, J., Piacentini, A., Plu, M., Poupkou, A., Queguiner, S., Robertson, L., Rouil, L., Schaap, M., Segers, A., Sofiev, M., Tarasson, L., Thomas, M., Timmermans, R., Valdebenito, A., van Velthoven, P., van Versendaal, R., Vira, J. and Ung, A. (2015). A regional air quality forecasting system over Europe: the MACC-II daily ensemble production. Geosci. Model Dev., 8 (9). S. 2777 - 2814. GOTTINGEN: COPERNICUS GESELLSCHAFT MBH. ISSN 1991-9603

Michels, S., Gardizi, M., Schultheis, A., Scheffler, M., Karachaliou, N., Teixido, C., Heukamp, L., Merkelbach-Bruse, S., Thurat, M., Nogova, L., Bos, M., Mattonet, C., Grohe, C., Sebastian, M., Thomas, M., Reck, M., Stahel, R., Pirker, R., Zoechbauer-Mueller, S., Groen, H., Dingemanns, A. -M, Smit, E., Thomas, R., Buettner, R., Massuti, B., Rosell, R. and Wolf, J. (2014). EUCROSS: A phase II trial to evaluate efficacy and safety of crizotinib treatment in advanced adenocarcinoma of the lung harbouring ROS1 translocations. Oncol. Res. Treat., 37. S. 65 - 66. BASEL: KARGER. ISSN 2296-5262

Michels, S., Thurat, M., Schmalz, P., Pereira, E., Scheffler, M., Fischer, R., Sebastian, M., Abreu, D. R., Carcereny, E., Corral, J. J., Felip, E., Grohe, C., Insa, A., Thomas, M., Reck, M., Rothschild, S., Brandes, V, Nogova, L., Merkelbach-Bruse, S., Massuti, B., Buettner, R., Rosell, R. and Wolf, J. (2016). EUCROSS: A European phase II trial to evaluate efficacy and safety of crizotinib treatment in advanced adenocarcinoma of the lung harbouring ROS1 translocations - Preliminary results. Oncol. Res. Treat., 39. S. 209 - 211. BASEL: KARGER. ISSN 2296-5262

Mulder, Frits I., Candeloro, Matteo, Kamphuisen, Pieter W., Di Nisio, Marcello, Bossuyt, Patrick M., Guman, Noori, Smit, Kirsten, Buller, Harry R., van Es, Nick, Abdel-Razeq, H., Ades, S., Ayappan, S. R., Borchmann, S., Cella, C. A., Fankhauser, C. D., Ferroni, P., Fuentes, H. E., Kruger, S., Lim, S. H., Lubberts, S., Lustig, D. B., Mansfield, A. S., Munoz Martin, A. J., Noble, S., Panizo, E., Papaxoinis, G., Park, K., Patel, J. N., Posch, F., Ramos, J. D., Roselli, M., Santi, R., Sohal, D., Srikanthan, A., Tafur, A. J., Terbuch, A., Thomas, M., Vathiotis, O., Wang, R. and Zahir, M. N. (2019). The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica, 104 (6). S. 1277 - 1288. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Thomas, M., Schuler, M., Potzner, M., Szczudlo, T., Sutradhar, S., Yovine, A. and Wolf, J. (2015). Experience from the ASCEND-1 trial: Ceritinib in patients (Pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) and brain metastases. Oncol. Res. Treat., 38. S. 270 - 271. BASEL: KARGER. ISSN 2296-5262

Thomas, M., Wolf, J., Schuler, M., Goldwasser, M., Boral, A. and Shaw, A. T. (2014). Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC. Oncol. Res. Treat., 37. S. 89 - 91. BASEL: KARGER. ISSN 2296-5262

Wolf, J., Han, J., Nishio, M., Souquet, P., Paz-Ares, L., De Marinis, F., Seto, T., De Jonge, M., Kim, T. M., Vansteenkiste, J., Tan, D., Garon, E., Groen, H., Hochmair, M., Felip, E., Reguart, N., Thomas, M., Overbeck, T., Ohashi, K., Giovannini, M., Yura, R., Joshi, A., Akimov, M. and Heist, R. (2017). GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC. J. Thorac. Oncol., 12 (11). S. S2399 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Wolf, J., Han, J., Nishio, M., Souquet, P., Paz-Ares, L., De Marinis, F., Seto, T., De Jonge, M., Kim, T. M., Vansteenkiste, J., Tan, D. S. W., Garon, E. B., Groen, H., Hochmair, M. J., Felip, E., Reguart, N., Thomas, M., Overbeck, T., Ohashi, K., Giovannini, M., Yura, R., Joshi, A., Akimov, M. and Heist, R. (2017). GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR wt, MET-dysregulated Advanced NSCLC. J. Thorac. Oncol., 12 (11). S. S1578 - 2. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

This list was generated on Sun Oct 17 04:21:09 2021 CEST.